These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17668898)

  • 1. Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes.
    Stoloff GA; Caparros-Wanderley W
    Eur J Immunol; 2007 Sep; 37(9):2441-9. PubMed ID: 17668898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protective and non-protective T cell epitopes in influenza.
    Crowe SR; Miller SC; Woodland DL
    Vaccine; 2006 Jan; 24(4):452-6. PubMed ID: 16140438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
    Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
    Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
    Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
    Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ
    J Immunol; 2006 May; 176(9):5141-50. PubMed ID: 16621977
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered immunodominance hierarchies of influenza A virus-specific H-2(b)-restricted CD8+ T cells in the absence of terminal deoxynucleotidyl transferase.
    Leon-Ponte M; Kasprzyski T; Mannik LA; Haeryfar SM
    Immunol Invest; 2008; 37(7):714-25. PubMed ID: 18821218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.
    Turner SJ; Kedzierska K; Komodromou H; La Gruta NL; Dunstone MA; Webb AI; Webby R; Walden H; Xie W; McCluskey J; Purcell AW; Rossjohn J; Doherty PC
    Nat Immunol; 2005 Apr; 6(4):382-9. PubMed ID: 15735650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typing of human and animal strains of influenza virus with conserved signature peptides of matrix M1 protein by high resolution mass spectrometry.
    Schwahn AB; Wong JW; Downard KM
    J Virol Methods; 2010 May; 165(2):178-85. PubMed ID: 20117137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunity against influenza virus infection].
    Takada A
    Nihon Rinsho; 2010 Sep; 68(9):1625-30. PubMed ID: 20845738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice.
    Lico C; Mancini C; Italiani P; Betti C; Boraschi D; Benvenuto E; Baschieri S
    Vaccine; 2009 Aug; 27(37):5069-76. PubMed ID: 19563889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus.
    Wang YS; Fan HJ; Li Y; Shi ZL; Pan Y; Lu CP
    Vaccine; 2007 May; 25(22):4447-55. PubMed ID: 17445956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
    Holman DH; Wang D; Raja NU; Luo M; Moore KM; Woraratanadharm J; Mytle N; Dong JY
    Vaccine; 2008 May; 26(21):2627-39. PubMed ID: 18395306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge.
    Park KS; Lee J; Ahn SS; Byun YH; Seong BL; Baek YH; Song MS; Choi YK; Na YJ; Hwang I; Sung YC; Lee CG
    Virology; 2009 Dec; 395(2):182-9. PubMed ID: 19836045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.